Life at Cipla Health
Extensive Research in
Consumer Healthcare – 2013
Launch of Nicotex as
an OTC brand – August 2014
Becoming an Independent
Company – 1st March 2016
Launch of ActivKids Immuno Boosters
Our first independently
developed product in a unique format – November 2016
Completed one year of independent
operations – 1st March 2017
Moving into our
new office – March 2017
At Cipla, it is our vision to become the most preferred consumer healthcare company in India. When we started out with our quest to create innovative health solutions for our consumers, we realized it is important to understand their needs first. So we conducted thousands of surveys to understand their genuine needs in healthcare and lifestyle. The year 2013 was a year of gathering tremendous amount of insights into the consumer.
The launch of Nicotex as an OTC brand in August 2014 was our first milestone as a company. While it was an existing brand, it only existed in the doctor’s prescription. The transition to OTC brought it close to the customer and started a journey of consumer education which still continues. The media campaigns around it have won us a number of awards since then.
In August 2015 we got our first independent Investor, Fidelity who joined our journey by investing in our future. In March 2016 CHL spun off as an independent subsidiary of Cipla.
The next milestone was the launch of our first independently developed product – ActivKids Immuno Boosters (AKIB) in November 2016. It is a perfect example of good science meeting good sensorial – an immunity boosting product for kids, delivered in the form of a chocolate – a format kids already love.
Numerous other products are in the pipeline, all based on extensive research, deep consumer insight and a constant endeavor to offer consumers solutions that give them what they need with the least amount of disruption.